{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:12:48Z","timestamp":1783440768554,"version":"3.54.6"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Several mutations of bilirubin uridine diphosphate-glucuronosyltransferase gene (UGT1A1) have been reported in patients with unconjugated hyperbilirubinemia. Few reports are available about the p.Pro364Leu mutation (P364L, c.1091C\u2009&gt;\u2009T) in homozygous newborns. We describe the clinical, laboratory and therapeutic approach in two Chinese neonates with severe jaundice, homozygous for the P364L mutation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Two Chinese breastfed female infants presented prolonged unconjugated hyperbilirubinemia at the age of 1\u00a0month. Total bilirubin was higher than 15\u00a0mg\/dl (D\u2009&lt;\u20091). An exhaustive etiological work-up to detect possible causes of hyperbilirubinemia (notably hemolytic ones) was negative.<\/jats:p>\n                <jats:p>The promoter and coding regions of UGT1A1 were amplified by polymerase chain reaction (PCR) from genomic DNA isolated from leukocytes. Both patients resulted homozygous for a variant site within the coding region of the gene in the 4 exon, c.1091C\u2009&gt;\u2009T, p.Pro364Leu.<\/jats:p>\n                <jats:p>In front of the persistently high level of unconjugated bilirubin, phototherapy was performed without persistent results. A treatment with phenobarbital was then begun and bilirubin level progressively decreased, with a complete and persistent normalization. The therapy was stopped.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>UGT1A1 enzyme activity associated with the P364L mutation has been described as 35.6% of the wild-type enzyme activity. Photo-therapy and phenobarbital can be useful in front of persistently high level of unconjugated bilirubin.<\/jats:p>\n                <jats:p>Our cases presented high bilirubin values, overlapping between Gilbert syndrome (GS) and Crigler-Najjar syndrome type II (CNS), but the complete normalization of bilirubin makes GS more likely. Homozygous P364L variant can be associated with severe neonatal unconjugated hyperbilirubinemia in Chinese infants, but jaundice can completely resolve in a few months, contrary to what happens in Crigler-Najjar syndrome type II.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-022-01251-4","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T08:02:41Z","timestamp":1650268961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gilbert or Crigler\u2013Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity"],"prefix":"10.1186","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2764-2161","authenticated-orcid":false,"given":"Laura","family":"Cozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-4524","authenticated-orcid":false,"given":"Federica","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Degrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Civeriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Paolella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-7722","authenticated-orcid":false,"given":"Gabriella","family":"Nebbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"1251_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/00008571-200008000-00007","volume":"10","author":"CS Huang","year":"2000","unstructured":"Huang CS, Luo GA, Huang MJ, Yu SC, Yang SS. Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics. 2000;10:539\u201344.","journal-title":"Pharmacogenetics"},{"key":"1251_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1440-1746.2004.03370.x","volume":"19","author":"K Takeuchi","year":"2004","unstructured":"Takeuchi K, Kobayashi Y, Tamaki S, Ishihara T, Maruo Y, Araki J, et al. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert\u2019s syndrome as well as in healthy Japanese subjects. J Gastroenterol Hepatol. 2004;19:1023\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"1251_CR3","doi-asserted-by":"crossref","unstructured":"Abuduxikuer K, Fang LJ, Li LT, Gong JY, Wang JS. UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: a retrospective analysis and quantitative correlation.\u00a0Med. 2018;97(49):e13576.","DOI":"10.1097\/MD.0000000000013576"},{"issue":"5","key":"1251_CR4","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1542\/peds.106.5.e59","volume":"106","author":"Y Maruo","year":"2000","unstructured":"Maruo Y, Nishizawa K, Sato H, Sawa H, Shimada M. Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics. 2000;106(5):E59.","journal-title":"Pediatrics"},{"issue":"45","key":"1251_CR5","doi-asserted-by":"publisher","first-page":"e8620","DOI":"10.1097\/MD.0000000000008620","volume":"96","author":"L Sun","year":"2017","unstructured":"Sun L, Li M, Zhang L, Teng X, Chen X, et al. Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler- Najjar syndrome type II. Medicine (Baltimore). 2017;96(45):e8620.","journal-title":"Medicine (Baltimore)"},{"key":"1251_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0925-4439(98)00013-1","volume":"1406","author":"K Yamamoto","year":"1998","unstructured":"Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutations G71R and Y486D of the bilirubin UDP glycosyltransferase gene to phenotypes of Gilbert\u2019s syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta. 1998;1406:267\u201373.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/bj1960257","volume":"196","author":"N Kawade","year":"1981","unstructured":"Kawade N, Onishi S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J. 1981;196(1):257\u201360.","journal-title":"Biochem J"},{"key":"1251_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40246-021-00331-6","volume":"15","author":"CL Meng","year":"2021","unstructured":"Meng CL, Zhao W, Zhong DN. Epigenetics and microRNAs in UGT1As. Hum Genomics. 2021;15:30.","journal-title":"Hum Genomics"},{"key":"1251_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pedneo.2015.08.008","volume":"57","author":"H Yang","year":"2016","unstructured":"Yang H, Wang Q, Zheng L, Zheng XB, Lin M, Zhan XF, et al. Clinical significance of UGT1A1 genetic analysis in Chinese neonates with severe hyperbilirubinemia. Pediatr Neonatol. 2016;57:310\u20137.","journal-title":"Pediatr Neonatol"},{"issue":"5","key":"1251_CR10","doi-asserted-by":"publisher","first-page":"e0126263","DOI":"10.1371\/journal.pone.0126263","volume":"10","author":"L Li","year":"2015","unstructured":"Li L, Deng G, Tang Y, Mao Q. Spectrum of UGT1A1 variations in Chinese patients with Crigler-Najjar Syndrome Type II. PLoS One. 2015;10(5):e0126263.","journal-title":"PLoS One"},{"issue":"1","key":"1251_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gene.2014.09.009","volume":"552","author":"Z Chen","year":"2014","unstructured":"Chen Z, Su D, Ai L, Jiang X, Wu C, et al. UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis. Gene. 2014;552(1):32\u20138.","journal-title":"Gene"},{"key":"1251_CR12","doi-asserted-by":"crossref","unstructured":"Satrom KM, Gourley GR. Neonatal jaundice and disorders of bilirubin metabolism. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver disease in children. 5th ed. Cambridge University Press; 2021. p. 182\u2013203.","DOI":"10.1017\/9781108918978.012"},{"issue":"6","key":"1251_CR13","doi-asserted-by":"publisher","first-page":"F461","DOI":"10.1136\/adc.2010.184416","volume":"96","author":"GL Preer","year":"2011","unstructured":"Preer GL, Philipp BL. Understanding and managing breast milk jaundice. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):F461\u20136.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"1251_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0022-3476(81)80963-8","volume":"99","author":"RL Poland","year":"1981","unstructured":"Poland RL. Breast-milk jaundice. J Pediatr. 1981;99(1):86\u20138.","journal-title":"J Pediatr"},{"issue":"3\u20134","key":"1251_CR15","first-page":"237","volume":"67","author":"MS El-Kholy","year":"1992","unstructured":"El-Kholy MS, Halim HY, Marzouk AH. Beta-glucuronidase and hyperbilirubinemia in breast-fed versus formula-fed babies. J Egypt Public Health Assoc. 1992;67(3\u20134):237\u201348.","journal-title":"J Egypt Public Health Assoc"},{"issue":"5","key":"1251_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1203\/PDR.0b013e31822f242e","volume":"70","author":"Y Ota","year":"2011","unstructured":"Ota Y, Maruo Y, Matsui K, Mimura Y, Sato H, Takeuchi Y. Inhibitory effect of 5\u03b2-pregnane-3\u03b1,20\u03b2-diol on transcriptional activity and enzyme activity of human bilirubin UDP-glucuronosyltransferase. Pediatr Res. 2011;70(5):453\u20137.","journal-title":"Pediatr Res"},{"issue":"6","key":"1251_CR17","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/hep.30959","volume":"71","author":"KA Strauss","year":"2020","unstructured":"Strauss KA, Ahlfors CE, Soltys K, Mazareigos GV, Young M, Bowser LE, Fox MD, Squires JE, McKiernan P, Brigatti KW, Puffenberger EG, Carson VJ, Vreman HJ. Crigler-Najjar Syndrome Type 1: pathophysiology, natural history, and therapeutic frontier. Hepatology. 2020;71(6):1923\u201339.","journal-title":"Hepatology"},{"issue":"5","key":"1251_CR18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/jhep.2001.24172","volume":"33","author":"J Sugatani","year":"2001","unstructured":"Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong Q, Owens I, Negishi M, Sueyoshi T. The phenobarbital response enhancer module in the human bilirubin UDP-Glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology. 2001;33(5):1232\u20138.","journal-title":"Hepatology"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-022-01251-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T11:13:17Z","timestamp":1650366797000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-022-01251-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1186\/s13052-022-01251-4","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"4 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}